Andrew Balo
2018
In 2018, Andrew Balo earned a total compensation of $3.2M as EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development at DexCom, a 5% increase compared to previous year.
Compensation breakdown
| Bonus | $7,500 |
|---|---|
| Non-Equity Incentive Plan | $461,108 |
| Salary | $365,959 |
| Stock Awards | $2,317,820 |
| Other | $22,251 |
| Total | $3,174,638 |
Balo received $2.3M in stock awards, accounting for 73% of the total pay in 2018.
Balo also received $7.5K in bonus, $461.1K in non-equity incentive plan, $366K in salary and $22.3K in other compensation.
Rankings
In 2018, Andrew Balo's compensation ranked 3,636th out of 14,244 executives tracked by ExecPay. In other words, Balo earned more than 74.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,636 out of 14,244 | 75th |
Division Manufacturing | 1,348 out of 5,762 | 77th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 162 out of 849 | 81st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 88 out of 547 | 84th |
Industry Surgical and Medical Instruments and Apparatus | 56 out of 348 | 84th |
Pay ratio
| Andrew Balo's Pay | $3,174,638 |
|---|---|
| Median Employee's Pay | $80,723 |
| Pay Ratio | 39to 1 |
In 2018, the annual total compensation of Andrew Balo was $3,174,638.
The annual total compensation of the median employee at DexCom was $80,723.
The ratio of Andrew Balo's pay to the pay of median employee was therefore 39 to one.
Source: SEC filing on April 19, 2019.
Balo's colleagues
We found four more compensation records of executives who worked with Andrew Balo at DexCom in 2018.